ASP Isotopes (ASPI) welcomes a group of 27 investors from 9 different countries to its ... The company will also provide updates on the commissioning phase for both the Silicon-28 and the ...
Both isotopes are urgently required; Silicon-28 to further advance next generation semiconductors and Yterrbium-176 to further advance oncology treatments that will improve patient outcomes.
ASP Isotopes is ahead of schedule on commissioning its Silicon-28 and Ytterbium-176 facilities, with commercial production expected to start in Q1 2025. Additionally, the first shipment of Carbon ...